Catheter Precision Statistics
Total Valuation
VTAK has a market cap or net worth of $2.99 million. The enterprise value is $2.06 million.
Important Dates
The next estimated earnings date is Monday, May 5, 2025, after market close.
| Earnings Date | May 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
VTAK has 9.27 million shares outstanding. The number of shares has increased by 493.91% in one year.
| Current Share Class | 9.27M |
| Shares Outstanding | 9.27M |
| Shares Change (YoY) | +493.91% |
| Shares Change (QoQ) | +362.86% |
| Owned by Insiders (%) | 8.29% |
| Owned by Institutions (%) | 9.97% |
| Float | 7.57M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.59 |
| Forward PS | 0.80 |
| PB Ratio | 0.23 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.91 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.58, with a Debt / Equity ratio of 0.16.
| Current Ratio | 1.58 |
| Quick Ratio | 1.41 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -123.55 |
Financial Efficiency
Return on equity (ROE) is -101.02% and return on invested capital (ROIC) is -39.96%.
| Return on Equity (ROE) | -101.02% |
| Return on Assets (ROA) | -24.02% |
| Return on Invested Capital (ROIC) | -39.96% |
| Return on Capital Employed (ROCE) | -43.77% |
| Revenue Per Employee | $19,091 |
| Profits Per Employee | -$990,955 |
| Employee Count | 22 |
| Asset Turnover | 0.01 |
| Inventory Turnover | 1.09 |
Taxes
In the past 12 months, VTAK has paid $3.14 million in taxes.
| Income Tax | 3.14M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -93.35% in the last 52 weeks. The beta is -0.44, so VTAK's price volatility has been lower than the market average.
| Beta (5Y) | -0.44 |
| 52-Week Price Change | -93.35% |
| 50-Day Moving Average | 0.36 |
| 200-Day Moving Average | 0.85 |
| Relative Strength Index (RSI) | 43.37 |
| Average Volume (20 Days) | 75,064 |
Short Selling Information
The latest short interest is 90,106, so 0.97% of the outstanding shares have been sold short.
| Short Interest | 90,106 |
| Short Previous Month | 116,413 |
| Short % of Shares Out | 0.97% |
| Short % of Float | 1.19% |
| Short Ratio (days to cover) | 0.74 |
Income Statement
In the last 12 months, VTAK had revenue of $420,000 and -$21.80 million in losses. Loss per share was -$6.68.
| Revenue | 420,000 |
| Gross Profit | 378,000 |
| Operating Income | -11.24M |
| Pretax Income | -6.85M |
| Net Income | -21.80M |
| EBITDA | -9.13M |
| EBIT | -11.24M |
| Loss Per Share | -$6.68 |
Full Income StatementBalance Sheet
The company has $2.87 million in cash and $1.85 million in debt, giving a net cash position of $1.02 million or $0.11 per share.
| Cash & Cash Equivalents | 2.87M |
| Total Debt | 1.85M |
| Net Cash | 1.02M |
| Net Cash Per Share | $0.11 |
| Equity (Book Value) | 11.76M |
| Book Value Per Share | 1.47 |
| Working Capital | 1.21M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$9.27 million and capital expenditures -$67,000, giving a free cash flow of -$9.34 million.
| Operating Cash Flow | -9.27M |
| Capital Expenditures | -67,000 |
| Free Cash Flow | -9.34M |
| FCF Per Share | -$1.01 |
Full Cash Flow StatementMargins
| Gross Margin | 90.00% |
| Operating Margin | -2,676.90% |
| Pretax Margin | -3,214.76% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |